Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transient receptor potential cation channel subfamily A member 1 | 0.546 | 0.846 | 7.2E-35 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1992 | 1993 | ||||||||
|
glycogen synthase kinase 3 beta | 0.430 | 0.846 | 0.96 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
transforming growth factor beta 2 | 0.433 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
secreted LY6/PLAUR domain containing 1 | 0.560 | 0.654 | 0.26 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
secreted LY6/PLAUR domain containing 1 | 0.560 | 0.654 | 0.26 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
serpin family A member 6 | 0.606 | 0.731 | 8.3E-07 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2006 | 2010 | ||||||||
|
calcium voltage-gated channel auxiliary subunit gamma 2 | 0.729 | 0.385 | 0.92 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
glutamate dehydrogenase 1 | 0.584 | 0.731 | 7.0E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1 | 0.564 | 0.654 | 1.00 |
|
disease | 0.230 | None | 1.000 | 1 | 0 | 2004 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2013 | 2018 | ||||||||
|
neuropeptide Y receptor Y1 | 0.628 | 0.423 | 4.3E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
neuropeptide Y receptor Y2 | 0.612 | 0.577 | 3.6E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
neuropeptide Y receptor Y5 | 0.691 | 0.462 | 6.4E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 0.475 | 0.846 | 0.94 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
disease | 0.760 | strong | 1.000 | 1 | 0 | 1996 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
SRY-box transcription factor 9 | 0.419 | 0.846 | 1.00 |
|
disease | 0.690 | None | 1.000 | 3 | 0 | 2000 | 2018 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2011 | 2016 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
limb development membrane protein 1 | 0.619 | 0.308 | 1.3E-08 |
|
disease | 0.820 | strong | 1.000 | 1 | 0 | 2001 | 2016 | ||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2006 | 2006 |